🇺🇸 FDA
Patent

US 9133162

Substituted quinoline compounds and methods of use

granted A61KA61K31/436A61K31/4709

Quick answer

US patent 9133162 (Substituted quinoline compounds and methods of use) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/436, A61K31/4709, A61K38/21, A61K45/06